Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1066682
  • May 2021
  • Biotechnology
  • 143 Pages
The global Next-generation Antibody market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Next-generation Antibody market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Next-generation Antibody market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Next-generation Antibody market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered F. Hoffmann-La Roche Ltd, Kyowa Hakko Kirin Co., Ltd., Seattle Genetics, Inc., ImmunoGen, Inc., Bristol-Myers Squibb Company, Pfizer, Inc., Amgen, Inc., Biogen, Bayer AG, Xencor, Inc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Next-generation Antibody market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Next-generation Antibody market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Next-generation Antibody market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Next-generation Antibody market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Next-generation Antibody Market:
The Next-generation Antibody market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. F. Hoffmann-La Roche Ltd, Kyowa Hakko Kirin Co., Ltd., Seattle Genetics, Inc., ImmunoGen, Inc., Bristol-Myers Squibb Company, Pfizer, Inc., Amgen, Inc., Biogen, Bayer AG, Xencor, Inc.

Next-generation Antibody Market Segment Analysis:
by Therapeutic Area
Oncology
Autoimmune or Inflammatory
Technology
Antibody-drug conjugates
Bispecific antibodies
Fc engineered antibodies
Antibody fragments and antibody-like proteins
Biosimilar antibody products


Geographic Coverage for Next-generation Antibody Market:
The market research report on global Next-generation Antibody market offers complete analysis across various regions across the world. The Next-generation Antibody market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Next-generation Antibody market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Next-generation Antibody Market Value and Forecast
  • US
  • Canada
Europe Next-generation Antibody Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Next-generation Antibody Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Next-generation Antibody Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Next-generation Antibody Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Next-generation Antibody market report:
  • The report provides key trends of the global Next-generation Antibody market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Next-generation Antibody industry
  • The report covers all the recent developments of the Next-generation Antibody market and helps to provide current industry updates
  • The report covers a detailed look over the global Next-generation Antibody Industry and provides with significant actionable insights
  • The Next-generation Antibody market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Next-generation Antibody market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Next-generation Antibody market
  • Comprehensive analysis of the Next-generation Antibody market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Next-generation Antibody market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Next-generation Antibody market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Next-generation Antibody market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Next-generation Antibody market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Next-generation Antibody market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • F. Hoffmann-La Roche Ltd
  • Kyowa Hakko Kirin Co., Ltd.
  • Seattle Genetics, Inc.
  • ImmunoGen, Inc.
  • Bristol-Myers Squibb Company
  • Pfizer, Inc.
  • Amgen, Inc.
  • Biogen
  • Bayer AG
  • Xencor, Inc.
  • Oncology
  • Autoimmune or Inflammatory
  • Antibody-drug conjugates
  • Bispecific antibodies
  • Fc engineered antibodies
  • Antibody fragments and antibody-like proteins
  • Biosimilar antibody products

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Next-generation Antibody Market Snapshot
          2.1.1. Global Next-generation Antibody Market By Therapeutic Area,2019
               2.1.1.1.Oncology
               2.1.1.2.Autoimmune or Inflammatory
          2.1.2. Global Next-generation Antibody Market By Technology,2019
               2.1.2.1.Antibody-drug conjugates
               2.1.2.2.Bispecific antibodies
               2.1.2.3.Fc engineered antibodies
               2.1.2.4.Antibody fragments and antibody-like proteins
               2.1.2.5.Biosimilar antibody products
          2.1.3. Global Next-generation Antibody Market By End-use,2019
          2.1.4. Global Next-generation Antibody Market By Geography,2019

3. Global Next-generation Antibody Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Next-generation Antibody Market Size (US$), By Therapeutic Area, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Therapeutic Area, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Therapeutic Area, 2020
     4.2. Global Next-generation Antibody Market Size (US$), By Therapeutic Area, 2018 – 2028

5. Global Next-generation Antibody Market Size (US$), By Technology, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Technology, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Technology, 2020
     5.2. Global Next-generation Antibody Market Size (US$), By Technology, 2018 – 2028

6. Global Next-generation Antibody Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Next-generation Antibody Market Size (US$), By End-use, 2018 – 2028

7. Global Next-generation Antibody Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Next-generation Antibody Market Analysis, 2018 – 2028 
          7.2.1. North America Next-generation Antibody Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Next-generation Antibody Market Size (US$), By Therapeutic Area, 2018 – 2028
          7.2.3. North America Next-generation Antibody Market Size (US$), By Technology, 2018 – 2028
          7.2.4. North America Next-generation Antibody Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Next-generation Antibody Market Analysis, 2018 – 2028 
          7.3.1.  Europe Next-generation Antibody Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Next-generation Antibody Market Size (US$), By Therapeutic Area, 2018 – 2028
          7.3.3. Europe Next-generation Antibody Market Size (US$), By Technology, 2018 – 2028
          7.3.4. Europe Next-generation Antibody Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Next-generation Antibody Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Next-generation Antibody Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Next-generation Antibody Market Size (US$), By Therapeutic Area, 2018 – 2028
          7.4.3. Asia Pacific Next-generation Antibody Market Size (US$), By Technology, 2018 – 2028
          7.4.4. Asia Pacific Next-generation Antibody Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Next-generation Antibody Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Next-generation Antibody Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Next-generation Antibody Market Size (US$), By Therapeutic Area, 2018 – 2028
          7.5.3. Latin America Next-generation Antibody Market Size (US$), By Technology, 2018 – 2028
          7.5.4. Latin America Next-generation Antibody Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Next-generation Antibody Market Analysis, 2018 – 2028 
          7.6.1.  MEA Next-generation Antibody Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Next-generation Antibody Market Size (US$), By Therapeutic Area, 2018 – 2028
          7.6.3. MEA Next-generation Antibody Market Size (US$), By Technology, 2018 – 2028
          7.6.4. MEA Next-generation Antibody Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Next-generation Antibody Providers
        8.4.1 F. Hoffmann-La Roche Ltd
                8.4.1.1 Business Description
                8.4.1.2 F. Hoffmann-La Roche Ltd Geographic Operations
                8.4.1.3 F. Hoffmann-La Roche Ltd Financial Information
                8.4.1.4 F. Hoffmann-La Roche Ltd Product Positions/Portfolio
                8.4.1.5 F. Hoffmann-La Roche Ltd Key Developments
        8.4.2 Kyowa Hakko Kirin Co., Ltd.
                8.4.2.1 Business Description
                8.4.2.2 Kyowa Hakko Kirin Co., Ltd. Geographic Operations
                8.4.2.3 Kyowa Hakko Kirin Co., Ltd. Financial Information
                8.4.2.4 Kyowa Hakko Kirin Co., Ltd. Product Positions/Portfolio
                8.4.2.5 Kyowa Hakko Kirin Co., Ltd. Key Developments
        8.4.3 Seattle Genetics, Inc.
                8.4.3.1 Business Description
                8.4.3.2 Seattle Genetics, Inc. Geographic Operations
                8.4.3.3 Seattle Genetics, Inc. Financial Information
                8.4.3.4 Seattle Genetics, Inc. Product Positions/Portfolio
                8.4.3.5 Seattle Genetics, Inc. Key Developments
        8.4.4 ImmunoGen, Inc.
                8.4.4.1 Business Description
                8.4.4.2 ImmunoGen, Inc. Geographic Operations
                8.4.4.3 ImmunoGen, Inc. Financial Information
                8.4.4.4 ImmunoGen, Inc. Product Positions/Portfolio
                8.4.4.5 ImmunoGen, Inc. Key Developments
        8.4.5 Bristol-Myers Squibb Company
                8.4.5.1 Business Description
                8.4.5.2 Bristol-Myers Squibb Company Geographic Operations
                8.4.5.3 Bristol-Myers Squibb Company Financial Information
                8.4.5.4 Bristol-Myers Squibb Company Product Positions/Portfolio
                8.4.5.5 Bristol-Myers Squibb Company Key Developments
        8.4.6 Pfizer, Inc.
                8.4.6.1 Business Description
                8.4.6.2 Pfizer, Inc. Geographic Operations
                8.4.6.3 Pfizer, Inc. Financial Information
                8.4.6.4 Pfizer, Inc. Product Positions/Portfolio
                8.4.6.5 Pfizer, Inc. Key Developments
        8.4.7 Amgen, Inc.
                8.4.7.1 Business Description
                8.4.7.2 Amgen, Inc. Geographic Operations
                8.4.7.3 Amgen, Inc. Financial Information
                8.4.7.4 Amgen, Inc. Product Positions/Portfolio
                8.4.7.5 Amgen, Inc. Key Developments
        8.4.8 Biogen
                8.4.8.1 Business Description
                8.4.8.2 Biogen Geographic Operations
                8.4.8.3 Biogen Financial Information
                8.4.8.4 Biogen Product Positions/Portfolio
                8.4.8.5 Biogen Key Developments
        8.4.9 Bayer AG
                8.4.9.1 Business Description
                8.4.9.2 Bayer AG Geographic Operations
                8.4.9.3 Bayer AG Financial Information
                8.4.9.4 Bayer AG Product Positions/Portfolio
                8.4.9.5 Bayer AG Key Developments
        8.4.10 Xencor, Inc.
                8.4.10.1 Business Description
                8.4.10.2 Xencor, Inc. Geographic Operations
                8.4.10.3 Xencor, Inc. Financial Information
                8.4.10.4 Xencor, Inc. Product Positions/Portfolio
                8.4.10.5 Xencor, Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Next-generation Antibody Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Next-generation Antibody Market Revenue, By Therapeutic Area, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Next-generation Antibody Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Next-generation Antibody Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Next-generation Antibody Market Revenue, By Therapeutic Area, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Next-generation Antibody Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Next-generation Antibody Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Next-generation Antibody Market Revenue, By Therapeutic Area, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Next-generation Antibody Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Next-generation Antibody Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Next-generation Antibody Market Revenue, By Therapeutic Area, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Next-generation Antibody Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Next-generation Antibody Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Next-generation Antibody Market Revenue, By Therapeutic Area, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Next-generation Antibody Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Next-generation Antibody Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Next-generation Antibody: Market Segmentation 
FIG. 2 Global Next-generation Antibody Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Next-generation Antibody Market, By Therapeutic Area, 2019 (US$ Mn) 
FIG. 5 Global Next-generation Antibody Market, By Technology, 2019 (US$ Mn) 
FIG. 6 Global Next-generation Antibody Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Next-generation Antibody Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Next-generation Antibody Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Next-generation Antibody Providers, 2019
FIG. 11 Global Next-generation Antibody Market Revenue Contribution, By Therapeutic Area, 2019 & 2028 (Value %) 
FIG. 12 Global Next-generation Antibody Market Revenue Contribution, By Technology, 2019 & 2028 (Value %) 
FIG. 13 Global Next-generation Antibody Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Next-generation Antibody Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Next-generation Antibody Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Next-generation Antibody Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Next-generation Antibody Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Next-generation Antibody Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Next-generation Antibody market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Next-generation Antibody Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Next-generation Antibody Market Value, By Segment1, 2018 – 2028
TABLE  North America Next-generation Antibody Market Value, By Segment2, 2018 – 2028
TABLE  North America Next-generation Antibody Market Value, By Country, 2018 – 2028
TABLE  Europe Next-generation Antibody Market Value, By Segment1, 2018 – 2028
TABLE  Europe Next-generation Antibody Market Value, By Segment2, 2018 – 2028
TABLE  Europe Next-generation Antibody Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Next-generation Antibody Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Next-generation Antibody Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Next-generation Antibody Market Value, By Country, 2018 – 2028
TABLE  Latin America Next-generation Antibody Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Next-generation Antibody Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Next-generation Antibody Market Value, By Country, 2018 – 2028
TABLE  MEA Next-generation Antibody Market Value, By Segment1, 2018 – 2028
TABLE  MEA Next-generation Antibody Market Value, By Segment2, 2018 – 2028
TABLE  MEA Next-generation Antibody Market Value, By Country, 2018 – 2028
TABLE  F. Hoffmann-La Roche Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Kyowa Hakko Kirin Co., Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Seattle Genetics, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ImmunoGen, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bristol-Myers Squibb Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Amgen, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biogen: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bayer AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Xencor, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Next-generation Antibody Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Next-generation Antibody Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Next-generation Antibody Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Next-generation Antibody Market, By Geography, 2019 (US$ Mn)
FIG.  Global Next-generation Antibody Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Next-generation Antibody Providers, 2016
FIG.  Global Next-generation Antibody Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Autoimmune or Inflammatory Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Next-generation Antibody Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Bispecific antibodies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Fc engineered antibodies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Antibody fragments and antibody-like proteins Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Biosimilar antibody products Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Next-generation Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Next-generation Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Next-generation Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Next-generation Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Next-generation Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Next-generation Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Next-generation Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Next-generation Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Next-generation Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Next-generation Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Next-generation Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Next-generation Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Next-generation Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Next-generation Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Next-generation Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Next-generation Antibody Market Value, 2018 – 2028, (US$ Mn)